4.7 Article

Dickkopf-2 regulates the stem cell marker LGR5 in colorectal cancer via HNF4α1

Journal

ISCIENCE
Volume 24, Issue 5, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.isci.2021.102411

Keywords

-

Funding

  1. National Institutes of Health USA [RO1CA168670]

Ask authors/readers for more resources

Enhanced stemness in colorectal cancer is closely associated with the Wnt ligand DKK2, which plays a critical role in promoting tumor progression by increasing LGR5-expressing cells. DKK2 activates the proto-oncogene tyrosine-protein kinase Src through degrading HNF4 alpha 1 protein, contributing to the aggressiveness of colorectal cancer.
Enhanced stemness in colorectal cancer has been reported and it contributes to aggressive progression, but the underlying mechanisms remain unclear. Here we report a Wnt ligand, Dickkopf-2 (DKK2) is essential for developing colorectal cancer stemness. Genetic depletion of DKK2 in intestinal epithelial or stem cells reduced tumorigenesis and expression of the stem cell marker genes including LGR5 in a model of colitis-associated cancer. Sequential mutations in APC, KRAS, TP53, and SMAD4 genes in colonic organoids revealed a significant increase of DKK2 expression by APC knockout and further increased by additional KRAS and TP53 mutations. Moreover, DKK2 activates proto-oncogene tyrosine-protein kinse Src followed by increased LGR5 expressing cells in colorectal cancer through degradation of HNF4 alpha 1 protein. These findings suggest that DKK2 is required for colonic epithelial cells to enhance LGR5 expression during the progression of colorectal cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available